Moleculin Biotech
MBRX
MBRX
21 hedge funds and large institutions have $790K invested in Moleculin Biotech in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 1 closing their positions.
Holders
21
Holders Change
+3
Holders Change %
+16.67%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
AC
1
Armistice Capital
New York
|
$540K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$15.2K |
3 |
3
LPL Financial
San Diego,
California
|
$70.1K |
4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$6.84K |
5 |
5
Renaissance Technologies
New York
|
$19.5K |